PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Est. Return
55.52%
1 Year Est. Return
+55.52%
AUM
$16.4B
AUM Growth
-$1.45B
(-8.1%)
Holding
327
Top Buys
| 1 | +$283M | |
| 2 | +$127M | |
| 3 | +$123M | |
| 4 |
Snowflake
SNOW
|
+$101M |
| 5 |
Flex
FLEX
|
+$92.3M |
Top Sells
| 1 | +$144M | |
| 2 | +$124M | |
| 3 | +$123M | |
| 4 |
Broadcom
AVGO
|
+$114M |
| 5 |
Amphenol
APH
|
+$113M |
Sector Composition
| 1 | Technology | 39.77% |
| 2 | Financials | 20.29% |
| 3 | Healthcare | 15.67% |
| 4 | Communication Services | 11.2% |
| 5 | Consumer Discretionary | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Commault Systems
CVLT
$7.64B
| $66.9M | 0.41% |
423,843
+60,885
|
|
||
77
Trip.com Group
TCOM
$45.8B
| $66M | 0.4% |
1,037,768
+24,928
|
|
||
78
Arm
ARM
$175B
| $65.3M | 0.4% |
611,759
-152,180
|
|
||
79
Mastercard
MA
$507B
| $62.4M | 0.38% |
113,828
+20,520
|
|
||
80
Nu Holdings
NU
$72.5B
| $62.2M | 0.38% |
6,075,317
+704,907
|
|
||
81
Marvell Technology
MRVL
$75.8B
| $60.7M | 0.37% |
985,171
-715,645
|
|
||
82
Vertex Pharmaceuticals
VRTX
$107B
| $60.6M | 0.37% |
125,000
-50,000
|
|
||
83
Palantir
PLTR
$423B
| $60.1M | 0.37% |
711,647
+473,385
|
|
||
84
Astera Labs
ALAB
$26.6B
| $59.1M | 0.36% |
990,796
+33,365
|
|
||
85
Insmed
INSM
$35B
| $55.6M | 0.34% |
728,755
-1,245
|
|
||
86
JPMorgan Chase
JPM
$810B
| $54.9M | 0.33% |
224,007
-8,355
|
|
||
87
Mirum Pharmaceuticals
MIRM
$3.69B
| $52.9M | 0.32% |
1,175,000
+500,000
|
|
||
88
Brown & Brown
BRO
$29B
| $52.9M | 0.32% |
425,000
+12,500
|
|
||
89
Avidity Biosciences
RNA
$6.99B
| $52.8M | 0.32% |
1,788,868
+516,977
|
|
||
90
First Solar
FSLR
$24.9B
| $52.7M | 0.32% |
417,069
+169,320
|
|
||
91
Samsara
IOT
$21B
| $52.3M | 0.32% |
1,365,601
+476,172
|
|
||
92
Aflac
AFL
$57.6B
| $51.1M | 0.31% |
460,000
|
|
||
93
IBM
IBM
$262B
| $50.9M | 0.31% |
+204,741
|
|
||
94
Trupanion
TRUP
$1.84B
| $50.3M | 0.31% |
1,350,000
+100,000
|
|
||
95
Madrigal Pharmaceuticals
MDGL
$9.78B
| $49.8M | 0.3% |
150,220
+12,500
|
|
||
96
Zillow
Z
$17.7B
| $49.5M | 0.3% |
722,617
+270,167
|
|
||
|
BPMC
97
DELISTED
Blueprint Medicines
BPMC
| $47.9M | 0.29% |
541,379
-85,000
|
|
||
98
Boston Scientific
BSX
$147B
| $47.5M | 0.29% |
471,113
-3,567
|
|
||
99
Enliven Therapeutics
ELVN
$1.27B
| $46.5M | 0.28% |
2,365,294
-24,374
|
|
||
100
NewAmsterdam Pharma
NAMS
$4.1B
| $46.1M | 0.28% |
2,250,000
+500,000
|
|